These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 27520584)

  • 61. Cellular Stress Associated with Aneuploidy.
    Zhu J; Tsai HJ; Gordon MR; Li R
    Dev Cell; 2018 Feb; 44(4):420-431. PubMed ID: 29486194
    [TBL] [Abstract][Full Text] [Related]  

  • 62. NAFLD: Is There Anything New under the Sun?
    Lonardo A; Targher G
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895919
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Telomere Dysfunction in Nonalcoholic Fatty Liver Disease and Cryptogenic Cirrhosis.
    Laish I; Mannasse-Green B; Hadary R; Biron-Shental T; Konikoff FM; Amiel A; Kitay-Cohen Y
    Cytogenet Genome Res; 2016; 150(2):93-99. PubMed ID: 28006764
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Telomere Length, Aggregates, and Capture in Cirrhosis.
    Laish I; Mari A; Mannasse B; Hadary R; Konikoff FM; Amiel A; Kitay-Cohen Y
    Isr Med Assoc J; 2018 May; 20(5):295-299. PubMed ID: 29761675
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Asynchronous DNA replication and aneuploidy in lymphocytes of hepatocellular carcinoma patients.
    Hanna MO; Zayed NA; Darwish H; Girgis SI
    Cancer Genet; 2012 Dec; 205(12):636-43. PubMed ID: 23182962
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Asynchronous Replication in Lymphocytes from Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Laish I; Biron-Shental T; Katz H; Liberman M; Kitay-Cohen Y; Konikoff FM; Amiel A
    Cytogenet Genome Res; 2015; 145(1):35-41. PubMed ID: 25895441
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.
    Wong CR; Nguyen MH; Lim JK
    World J Gastroenterol; 2016 Oct; 22(37):8294-8303. PubMed ID: 27729736
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Potential epigenetic mechanism in non-alcoholic Fatty liver disease.
    Sun C; Fan JG; Qiao L
    Int J Mol Sci; 2015 Mar; 16(3):5161-79. PubMed ID: 25751727
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Aneuploidy and asynchronous replication in non-alcholic fatty liver disease and cryptogenic cirrhosis.
    Laish I; Mannasse-Green B; Hadary R; Konikoff FM; Amiel A; Kitay-Cohen Y
    Gene; 2016 Nov; 593(1):162-166. PubMed ID: 27520584
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Natural Course of Non-Alcoholic Fatty Liver Disease.
    Calzadilla Bertot L; Adams LA
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213358
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease.
    Panera N; Gnani D; Crudele A; Ceccarelli S; Nobili V; Alisi A
    World J Gastroenterol; 2014 Nov; 20(41):15079-86. PubMed ID: 25386056
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.